Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination Chemotherapy
Clinical trial NCT01504711 · COMPLETED
Trial details
- NCT number
- NCT01504711
- Sponsor
- Philip Philip
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2016-12-29
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.